Tocilizumab for giant cell arteritis: an amazing result


Isik M., KILIÇ L., Dogan I., Calguneri M.

RHEUMATOLOGY INTERNATIONAL, vol.33, no.11, pp.2961-2962, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 33 Issue: 11
  • Publication Date: 2013
  • Doi Number: 10.1007/s00296-012-2516-z
  • Journal Name: RHEUMATOLOGY INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.2961-2962
  • Hacettepe University Affiliated: Yes

Abstract

Giant cell arteritis (GCA), previously Horton's disease, is a systemic vasculitis affecting the middle-sized or large arteries in patients older than 50 years of age. The mainstay of the treatment of GCA is glucocorticoid therapy. Herein, we present a case with giant cell arteritis resistant to oral and intravenous steroid, intravenous cyclophosphamide and mycophenolate mofetil, but successfully treated with tocilizumab.